NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $444,211 | +0.9% | 4,361 | 0.0% | 0.07% | +3.1% |
| Q2 2023 | $440,069 | -16.6% | 4,361 | -24.0% | 0.06% | -20.7% |
| Q1 2023 | $527,620 | -0.3% | 5,735 | -1.7% | 0.08% | -3.5% |
| Q4 2022 | $529,351 | +12.2% | 5,835 | -6.1% | 0.08% | +1.2% |
| Q3 2022 | $472,000 | -10.1% | 6,215 | 0.0% | 0.08% | -7.7% |
| Q2 2022 | $525,000 | -3.8% | 6,215 | -0.1% | 0.09% | +7.1% |
| Q1 2022 | $546,000 | +2.4% | 6,220 | +2.1% | 0.08% | +2.4% |
| Q4 2021 | $533,000 | +11.7% | 6,095 | +4.5% | 0.08% | +1.2% |
| Q3 2021 | $477,000 | -10.3% | 5,835 | 0.0% | 0.08% | -9.9% |
| Q2 2021 | $532,000 | +20.4% | 5,835 | +12.8% | 0.09% | +9.6% |
| Q1 2021 | $442,000 | -6.9% | 5,172 | +2.9% | 0.08% | -13.5% |
| Q4 2020 | $475,000 | +129.5% | 5,027 | +111.0% | 0.10% | +95.9% |
| Q3 2020 | $207,000 | -99.8% | 2,382 | +120.6% | 0.05% | -46.2% |
| Q4 2017 | $90,677,000 | – | 1,080 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 335,936 | $29,213,000 | 5.81% |
| Martin Investment Management, LLC | 170,759 | $14,849,000 | 5.36% |
| Mawer Investment Management Ltd. | 8,515,391 | $740,498,000 | 4.84% |
| SCHARF INVESTMENTS, LLC | 1,212,354 | $105,426,000 | 4.54% |
| Hansberger Growth Investors, LP | 45,645 | $3,969,000 | 4.50% |
| GARLAND CAPITAL MANAGEMENT INC | 50,905 | $4,427,000 | 3.95% |
| First Fiduciary Investment Counsel, Inc. | 193,021 | $16,785,000 | 3.49% |
| PROFESSIONAL ADVISORY SERVICES INC | 224,087 | $19,487,000 | 3.48% |
| WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC | 362,047 | $31,484,000 | 3.29% |
| WILKINS INVESTMENT COUNSEL INC | 126,470 | $10,998,000 | 3.28% |